TPC
Takeda Pharmaceutical Company Portfolio holdings
AUM
$19.6M
This Quarter Return
+19.92%
1 Year Return
-13.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$327M
AUM Growth
–
Cap. Flow
+$327M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
99.54%
Holding
14
New
14
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
HilleVax
HLVX
|
$108M |
| 2 |
Denali Therapeutics
DNLI
|
$86.9M |
| 3 |
Phathom Pharmaceuticals
PHAT
|
$77.4M |
| 4 |
Ovid Therapeutics
OVID
|
$24.3M |
| 5 |
Shattuck Labs
STTK
|
$14.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
HilleVax
HLVX
$105M
| $108M | 32.95% | +6,724,000 | New | +$108M |
|
|
2
Denali Therapeutics
DNLI
$2.23B
| $86.9M | 26.55% | +4,214,559 | New | +$86.9M |
|
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $77.4M | 23.62% | +7,459,286 | New | +$77.4M |
|
|
4
Ovid Therapeutics
OVID
$91M
| $24.3M | 7.41% | +7,531,996 | New | +$24.3M |
|
|
5
Shattuck Labs
STTK
$47M
| $14.9M | 4.55% | +2,090,858 | New | +$14.9M |
|
6
Wave Life Sciences
WVE
$1.53B
| $7.57M | 2.31% | +1,346,892 | New | +$7.57M |
|
7
American Well
AMWL
$111M
| $2.32M | 0.71% | +1,554,669 | New | +$2.32M |
|
|
TSBX
8
DELISTED
Turnstone Biologics
TSBX
| $2.28M | 0.7% | +895,824 | New | +$2.28M |
|
9
Equillium
EQ
$62.2M
| $1.31M | 0.4% | +1,824,977 | New | +$1.31M |
|
10
Rani Therapeutics
RANI
$24.4M
| $1.12M | 0.34% | +338,679 | New | +$1.12M |
|
11
Xilio Therapeutics
XLO
$36.3M
| $811K | 0.25% | +1,475,121 | New | +$811K |
|
|
AKLI
12
DELISTED
Akili, Inc. Common Stock
AKLI
| $360K | 0.11% | +738,819 | New | +$360K |
|
|
JBIO
13
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $307K | 0.09% | +13,580 | New | +$307K |
|
14
Standard BioTools
LAB
$481M
| $36.5K | 0.01% | +16,515 | New | +$36.5K |
|